DuPont Titanium Technologies and Omya Inc. Announce Partnership
News Jun 28, 2013
DuPont Titanium Technologies has announced a new distribution agreement with Omya, Inc. Omya, through its subsidiary companies Durr Marketing Associates, Azalea Color Company and Lipscomb Chemical Company, will become a national distributor and represent DuPont Titanium Technologies’ products in all 50 U.S. states as well as Western Canada.
Omya is a worldwide distributor of specialty chemical products focused on Industrial and Life Science applications and a leading global producer of industrial minerals, mainly fillers and pigments derived from calcium carbonate and dolomite. Omya’s distribution network extends from coast to coast across the United States.
DuPont Titanium Technologies is the world's largest manufacturer of titanium dioxide, serving customers globally in the coatings, paper, plastics and laminates industries.
The company operates plants at DeLisle, Miss.; New Johnsonville, Tenn.; Edge Moor, Del.; Altamira, Mexico; and Kuan Yin, Taiwan; all of which use the chloride manufacturing process. The company also operates a mine in Starke, Fla.
“We see an outstanding fit between Omya’s approach to the markets we serve together and expect that this partnership will improve our market position and better serve our customers in North America,” said Miren Salsamendi, North America director, DuPont Titanium Technologies.
Tony Colak, CEO for Omya Region Americas stated, “We are very excited to extend our relationship with DuPont, the global market leader in titanium dioxide pigments which are critical to the formulations used by many of our customers.”
Metabolomic Profiling Identifies Taurine as New MS TherapeuticNews
New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.READ MORE
Chemists Have Synthesized New Isoquinoline DerivativesNews
Chemists have synthesized new isoquinoline derivatives. Due to their biological activity, these compounds may be applicable in new drugs, from antispasmodics to bactericidal agents. In addition, in the future they may show effectiveness in the treatment of Alzheimer's disease.READ MORE
Researchers Develop a Platform to Produce Brand-new AntibioticsNews
A team of scientists at the University of Bristol have generated a brand-new platform that will allow the production of desperately needed brand-new antibiotics.READ MORE